ISSN: 1044-579X

Journal Home

Journal Guideline

Seminars in Cancer Biology Q1 Unclaimed

Academic Press Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Seminars in Cancer Biology is a journal indexed in SJR in Cancer Research with an H index of 148. It has a price of 2840 €. It has an SJR impact factor of 3,908 and it has a best quartile of Q1. It is published in English.

Seminars in Cancer Biology focuses its scope in these topics and keywords: role, nuclear, cancer, natural, molecular, microrna, mechanismsthe, malignancy, lymphomagenesisa, inflammation, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q1)

Price

2840 €

Gold OA

-

Green OA

0 €

Non OA

Metrics

3,908

SJR Impact factor

148

H Index

287

Total Docs (Last Year)

310

Total Docs (3 years)

47920

Total Refs

3555

Total Cites (3 years)

286

Citable Docs (3 years)

11,39

Cites/Doc (2 years)

166,97

Ref/Doc

Other journals with similar parameters

JAMA oncology Q1
Cell Host and Microbe Q1
Molecular Cancer Q1
Journal of the National Cancer Institute Q1
Clinical Cancer Research Q1

Aims and Scope

Best articles

14-3-3 proteins and cancer biology

A broad-spectrum integrative design for cancer prevention and therapy: The challenge ahead

Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research

AGEs, RAGEs and s-RAGE; friend or foe for cancer

Alpha2beta1 integrin in cancer development and chemoresistance

Apoptosis and cancer: where we are and where to go ...

Assessing the anticancer effects associated with food products and/or nutraceuticals using in vitro and in vivo preclinical development-related pharmacological tests

Augmenting the immunogenicity of carbohydrate tumor antigens

Autocrine signaling in carcinoma: VEGF and the a6beta4 integrin

Breast cancer stem cells: Features, key drivers and treatment options

Burkitt lymphoma

Cancer stem cells: Differentiation block or developmental back-tracking?

SHOW MORE ARTICLES

Chemokines in neuroectodermal development and their potential implication in cancer stem cell-driven metastasis

Chemokines in neuroectodermal tumour progression and metastasis

Chromosomal translocation t(14;18) in healthy individuals

Commentary

Conditional animal models: a strategy to define when oncogenes will be effective targets to treat cancer

Connecting mitotic instability and chromosome aberrations in cancer - can telomeres bridge the gap?

Current criteria to establish human carcinogens

Cyclin E as a prognostic and predictive marker in breast cancer

Definition of tumor antigens suitable for vaccine construction

Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures

Epigenetic and proteolytic inactivation of 14-3-3s in breast and prostate cancers

Epitope selection and development of peptide based vaccines to treat cancer

Comments

No comments ... Be the first to comment!

Publication speed

Review quality

Edition and editorial team

Paper Link

Attach one of your papers. We need to confirm that you have had a relation with this journal in order to review its service.